aminoglutethimide has been researched along with Lung Neoplasms in 19 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "54 patients (pts) with metastatic breast cancer were treated with aminoglutethimide 250 mg p." | 7.69 | [Use of aminoglutethimide in the hormonal treatment of patients with advanced breast cancer]. ( Czech, I; Dziewulska-Bokiniec, A; Wojtacki, J, 1994) |
| "Aminoglutethimide (AG) was administered as palliative therapy in 112 patients with metastatic breast cancer." | 7.67 | Aminoglutethimide in patients with metastatic breast cancer. ( Dao, TL; Nemoto, T; Patel, JK; Rosner, D, 1989) |
| "Aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily was used to treat 76 postmenopausal women with advanced breast cancer." | 7.67 | Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Cantwell, BM; Dawes, PJ; Evans, RG; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R, 1986) |
| "In a phase II study, 38 evaluable patients with advanced progressive breast cancer were treated with 4 X 250 mg of aminoglutethimide per day without hydrocortisone supplementation." | 7.67 | Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer. ( Faber, P; Höffken, K; Kempf, H; Kley, HK; Miller, AA; Miller, B; Schmidt, CG, 1986) |
| "Five men with advanced breast cancer were treated with aminoglutethimide (AG) plus replacement dose hydrocortisone." | 7.67 | Role of aminoglutethimide in male breast cancer. ( Dowsett, M; Harris, AL; Smith, IE; Stuart-Harris, R, 1986) |
| "54 patients (pts) with metastatic breast cancer were treated with aminoglutethimide 250 mg p." | 3.69 | [Use of aminoglutethimide in the hormonal treatment of patients with advanced breast cancer]. ( Czech, I; Dziewulska-Bokiniec, A; Wojtacki, J, 1994) |
| "Aminoglutethimide (AG) was administered as palliative therapy in 112 patients with metastatic breast cancer." | 3.67 | Aminoglutethimide in patients with metastatic breast cancer. ( Dao, TL; Nemoto, T; Patel, JK; Rosner, D, 1989) |
| "Aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily was used to treat 76 postmenopausal women with advanced breast cancer." | 3.67 | Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Cantwell, BM; Dawes, PJ; Evans, RG; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R, 1986) |
| "In a phase II study, 38 evaluable patients with advanced progressive breast cancer were treated with 4 X 250 mg of aminoglutethimide per day without hydrocortisone supplementation." | 3.67 | Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer. ( Faber, P; Höffken, K; Kempf, H; Kley, HK; Miller, AA; Miller, B; Schmidt, CG, 1986) |
| "Five men with advanced breast cancer were treated with aminoglutethimide (AG) plus replacement dose hydrocortisone." | 3.67 | Role of aminoglutethimide in male breast cancer. ( Dowsett, M; Harris, AL; Smith, IE; Stuart-Harris, R, 1986) |
| "42 patients with metastatic breast carcinoma were treated with aminoglutethimide, which inhibits adrenal steroid hormone synthesis." | 1.26 | Aminoglutethimide in treatment of metastatic breast carcinoma. ( Fahmy, DR; Fitzharris, BM; Ford, HT; Gazet, JC; McKinna, JA; Nash, AG; Neville, AM; Powles, TJ; Smith, IE, 1978) |
| "Cushing syndrome is documented by laboratory examinations." | 1.26 | The treatment of ACTH Paraneoplastic syndrome with aminoglutethimide. ( Banks, D; Chapman, J; Chinn, B; Pearson, S; Vaughn, CB, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (78.95) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mustacchi, G | 1 |
| Muggia, M | 1 |
| Milani, S | 1 |
| Ceccherini, R | 1 |
| Leita, ML | 1 |
| Dellach, C | 1 |
| Spano, JP | 1 |
| Soria, JC | 1 |
| Kambouchner, M | 1 |
| Piperno-Neuman, S | 1 |
| Morin, F | 1 |
| Morere, JF | 1 |
| Martin, A | 1 |
| Breau, JL | 1 |
| Van Gaal, L | 1 |
| Delvigne, C | 1 |
| Abs, R | 1 |
| De Leeuw, I | 1 |
| Bekaert, J | 1 |
| Beccati, MD | 1 |
| Degli Azzi Vitelleschi, I | 1 |
| Marangolo, M | 1 |
| Smith, IE | 3 |
| Coombes, RC | 1 |
| Ford, HT | 2 |
| Gazet, JC | 2 |
| Harmer, C | 1 |
| Jones, M | 1 |
| McKinna, JA | 2 |
| Powles, TJ | 2 |
| Wojtacki, J | 1 |
| Dziewulska-Bokiniec, A | 1 |
| Czech, I | 1 |
| Oka, H | 1 |
| Emori, Y | 1 |
| Hayashi, Y | 1 |
| Nomoto, K | 1 |
| Fitzharris, BM | 1 |
| Fahmy, DR | 1 |
| Nash, AG | 1 |
| Neville, AM | 1 |
| Vaughn, CB | 1 |
| Pearson, S | 1 |
| Chapman, J | 1 |
| Chinn, B | 1 |
| Banks, D | 1 |
| Koelmeyer, TD | 1 |
| Woods, WP | 1 |
| Wells, SA | 1 |
| Santen, RJ | 1 |
| Lipton, A | 1 |
| Haagensen, DE | 1 |
| Ruby, EJ | 1 |
| Harvey, H | 1 |
| Dilley, WG | 1 |
| Nemoto, T | 1 |
| Rosner, D | 1 |
| Patel, JK | 1 |
| Dao, TL | 1 |
| Lê, MG | 1 |
| Maugeri, G | 1 |
| Masselot, J | 1 |
| May-Lévin, F | 1 |
| Sarrazin, D | 1 |
| Harris, AL | 2 |
| Cantwell, BM | 1 |
| Sainsbury, JR | 1 |
| Needham, G | 1 |
| Evans, RG | 1 |
| Dawes, PJ | 1 |
| Wilson, R | 1 |
| Farndon, J | 1 |
| Höffken, K | 1 |
| Kempf, H | 1 |
| Miller, AA | 1 |
| Miller, B | 1 |
| Schmidt, CG | 1 |
| Faber, P | 1 |
| Kley, HK | 1 |
| Dowsett, M | 1 |
| Stuart-Harris, R | 1 |
| Brun, J | 1 |
| Revol, A | 1 |
| Queneau, P | 1 |
| Rees, LH | 1 |
| Bloomfield, GA | 1 |
| Rees, GM | 1 |
| Corrin, B | 1 |
| Franks, LM | 1 |
| Ratcliffe, JG | 1 |
| Miranda-Zetterstrand, N | 1 |
| Díaz-Bonet, L | 1 |
| Pagán-Sáez, H | 1 |
| Rosaly de Jirau, W | 1 |
1 trial available for aminoglutethimide and Lung Neoplasms
| Article | Year |
|---|---|
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone | 2002 |
18 other studies available for aminoglutethimide and Lung Neoplasms
| Article | Year |
|---|---|
Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma.
Topics: Adult; Aminoglutethimide; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Disease-Free Surv | 2003 |
Cushing's syndrome, due to ectopic ACTH-secretion, successfully treated with aminoglutethimide, radiotherapy and chemotherapy.
Topics: Adrenocorticotropic Hormone; Adult; Aminoglutethimide; Carcinoma, Small Cell; Cushing Syndrome; Huma | 1981 |
[Pharmacological suppression of the adrenal gland. Considerations on a clinical case].
Topics: Adenocarcinoma, Mucinous; Adrenocortical Hyperfunction; Adult; Aminoglutethimide; Antineoplastic Age | 1982 |
Aminoglutethimide in the management of advanced breast cancer.
Topics: Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neo | 1980 |
[Use of aminoglutethimide in the hormonal treatment of patients with advanced breast cancer].
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; | 1994 |
Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4+ T cells in a murine model implanted with B16 melanoma.
Topics: Aminoglutethimide; Animals; CD4-Positive T-Lymphocytes; Cholesterol Side-Chain Cleavage Enzyme; Cort | 2000 |
Aminoglutethimide in treatment of metastatic breast carcinoma.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neopl | 1978 |
The treatment of ACTH Paraneoplastic syndrome with aminoglutethimide.
Topics: Adrenocorticotropic Hormone; Aminoglutethimide; Carcinoma, Small Cell; Cushing Syndrome; Female; Hum | 1979 |
Carcinoma of the lung presenting as Cushing's syndrome.
Topics: Aminoglutethimide; Carcinoma, Bronchogenic; Cortisone; Cushing Syndrome; Cyclophosphamide; Diagnosis | 1977 |
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Brea | 1978 |
Aminoglutethimide in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Fema | 1989 |
[Factors linked to the development of pleuro-pulmonary metastases in breast cancer. Preliminary study].
Topics: Aminoglutethimide; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Pleu | 1987 |
Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Resp | 1986 |
Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; | 1986 |
Role of aminoglutethimide in male breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Estradiol; Estrone; Humans; Hydrocor | 1986 |
[Broncho-pulmonary cancer with true or degraded hypercorticism].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocortical Hyperfunction; Adrenocorticotropic Hormon | 1969 |
Multiple hormones in a bronchial tumor.
Topics: Adrenocorticotropic Hormone; Aminoglutethimide; Carcinoma, Small Cell; Cells, Cultured; Female; Huma | 1974 |
Amino-glutethimide (elipten) in adenocortical carcinoma.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; A | 1968 |